Center of Medical Biochemistry, Vienna Biocenter, Max Perutz Laboratories, Medical University of Vienna, Dr. Bohr Gasse 9/3, 1030 Vienna, Austria.
Institut Pasteur, CEDEX 15, 75724 Paris, France.
Viruses. 2023 Apr 19;15(4):1003. doi: 10.3390/v15041003.
Rhinoviruses (RVs) are the major cause of common cold, a respiratory disease that generally takes a mild course. However, occasionally, RV infection can lead to serious complications in patients debilitated by other ailments, e.g., asthma. Colds are a huge socioeconomic burden as neither vaccines nor other treatments are available. The many existing drug candidates either stabilize the capsid or inhibit the viral RNA polymerase, the viral proteinases, or the functions of other non-structural viral proteins; however, none has been approved by the FDA. Focusing on the genomic RNA as a possible target for antivirals, we asked whether stabilizing RNA secondary structures might inhibit the viral replication cycle. These secondary structures include G-quadruplexes (GQs), which are guanine-rich sequence stretches forming planar guanine tetrads via Hoogsteen base pairing with two or more of them stacking on top of each other; a number of small molecular drug candidates increase the energy required for their unfolding. The propensity of G-quadruplex formation can be predicted with bioinformatics tools and is expressed as a GQ score. Synthetic RNA oligonucleotides derived from the RV-A2 genome with sequences corresponding to the highest and lowest GQ scores indeed exhibited characteristics of GQs. In vivo, the GQ-stabilizing compounds, pyridostatin and PhenDC3, interfered with viral uncoating in Na but not in K-containing phosphate buffers. The thermostability studies and ultrastructural imaging of protein-free viral RNA cores suggest that Na keeps the encapsulated genome more open, allowing PDS and PhenDC3 to diffuse into the quasi-crystalline RNA and promote the formation and/or stabilization of GQs; the resulting conformational changes impair RNA unraveling and release from the virion. Preliminary reports have been published.
鼻病毒(RVs)是普通感冒的主要原因,普通感冒通常是轻度疾病。然而,偶尔情况下,RV 感染会导致其他疾病(如哮喘)患者出现严重并发症。由于既没有疫苗也没有其他治疗方法,感冒给社会经济带来了巨大负担。许多现有的药物候选物要么稳定衣壳,要么抑制病毒 RNA 聚合酶、病毒蛋白酶或其他非结构病毒蛋白的功能;然而,这些药物都没有被 FDA 批准。鉴于基因组 RNA 可能是抗病毒药物的一个潜在靶点,我们询问了稳定 RNA 二级结构是否可能抑制病毒复制周期。这些二级结构包括 G-四联体(GQs),它们是富含鸟嘌呤的序列延伸,通过 Hoogsteen 碱基配对形成平面鸟嘌呤四联体,其中两个或更多的 G 四联体彼此堆叠;许多小分子药物候选物增加了它们展开所需的能量。G-四联体形成的倾向可以通过生物信息学工具预测,并表示为 GQ 评分。源自 RV-A2 基因组的具有与最高和最低 GQ 评分相对应序列的合成 RNA 寡核苷酸确实表现出 GQ 的特征。在体内,GQ 稳定化合物吡啶并硫酮和 PhenDC3 在 Na 缓冲液中而不是在含有 K 的磷酸盐缓冲液中干扰病毒脱壳。无蛋白病毒 RNA 核心的热稳定性研究和超微结构成像表明,Na 使包裹的基因组保持更开放,允许 PDS 和 PhenDC3 扩散到准晶状 RNA 中,并促进 GQ 的形成和/或稳定;由此产生的构象变化会损害 RNA 解缠和从病毒粒子中的释放。初步报告已经发表。